On the one side, hydrophilic STING agonists activate the STING pathway, upregulate interferon signaling-related genes and reshape suppressive TMEs, thereby promoting dendritic cell maturation and augmenting tumor-specific CD8+T cell infiltration. Here, CD8A is linked to neoplasm.